NeuroPace Inc
NPCE- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001528287
No open-market purchases or sales by NeuroPace Inc insiders were filed in the last 90 days; 112 institutions reported holding it in 13F filings for Q2 2026, worth $422.4M in total; no superinvestor holds it.
Q3 2025 vs. Q2 2025
How the institutions holding NeuroPace Inc changed between Q2 2025 and Q3 2025.
All holders in Q3 2025All holders in Q2 2025
| Measure | Q2 2025 | Q3 2025 | Change |
|---|---|---|---|
| Holders | 99 | 80 | −19 |
| Shares | 22.5M | 25.9M | +3.44M (+15.3%) |
| Value | $250.7M | $267.5M | +$16.8M (+6.7%) |
New holders (10)
Institutions that held NeuroPace Inc at the end of Q3 2025 but not at the end of Q2 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Polar Capital Holdings Plc | 3,097,868 | $31.9M | 0.15% |
| Los Angeles Capital Management LLC | 26,390 | $272.1K | 0.00% |
| Western Wealth Management, LLC | 23,000 | $237.1K | 0.01% |
| PharVision Advisers, LLC | 22,456 | $231.5K | 0.13% |
| Aquatic Capital Management LLC | 22,215 | $229.0K | 0.00% |
| Man Group plc | 19,706 | $203.2K | 0.00% |
| R Squared Ltd | 12,927 | $133.3K | 0.06% |
| XTX Topco Ltd | 10,992 | $113.3K | 0.01% |
| Optiver Holding B.V. | 432 | $4.45K | 0.00% |
| Harbour Investments, Inc. | 223 | $2.30K | 0.00% |
Sold out (29)
Institutions that held NeuroPace Inc at the end of Q2 2025 and filed for Q3 2025 without it.